Klivira
Request demo

Navigating Medicare Verzenio Prior Authorization

For high-cost pharmaceuticals like Verzenio, understanding the nuances of Medicare Verzenio prior authorization is critical for patient access and revenue integrity.

Revenue cycle directors and prior authorization teams face complex challenges when securing approvals for specialty medications under Medicare. Klivira's platform simplifies the often-fragmented process, ensuring submissions align with specific Medicare requirements.

Verzenio and Medicare Prior Authorization Scope

Verzenio is a high-volume prior authorization target across various payer types, including Medicare. It's crucial to distinguish between Original Medicare (Parts A and B), which has a limited scope for prior authorization, and Medicare Advantage (MA) plans, which often have expanded PA requirements. Pharmacy benefits under Medicare Part D are administered by private plans with their own formularies and utilization management protocols.

Original Medicare (Part A & B) PA for Verzenio

Where Original Medicare requires prior authorization for services that might include Verzenio administration (e.g., if covered under Part B as a medical benefit), submissions are routed through the responsible Medicare Administrative Contractor (MAC) for the provider's jurisdiction. MACs such as Noridian, NGS, WPS, Palmetto, FCSO, and Novitas manage these processes. Klivira's platform offers MAC-aware routing to handle these per-jurisdiction submission specifics.

Medicare Part D Pharmacy PA for Verzenio

For Verzenio prescriptions covered under Medicare Part D, prior authorization is managed by the private plans that administer these benefits. These plans operate under CMS-approved formularies and may implement step-therapy protocols or quantity limits. Klivira integrates with the various PBMs and portals used by Part D plans to streamline these pharmacy benefit prior authorization submissions.

Policy Adherence: National and Local Coverage Determinations

Medicare coverage decisions for drugs and services are guided by National Coverage Determinations (NCDs) published by CMS, and Local Coverage Determinations (LCDs) issued by individual MACs. For any Verzenio prior authorization under Original Medicare, submissions must demonstrate adherence to the relevant NCD number or LCD ID, specific to the MAC jurisdiction and its effective date. Klivira's NCD/LCD-aware policy logic assists in structuring compliant submissions.

Streamlining Medicare PA Workflows with Klivira

Klivira's platform automates the prior authorization process for specialty medications like Verzenio, reducing the administrative burden on PA coordinators. By connecting directly to MAC-jurisdiction submission channels and Part D payer portals, Klivira helps ensure that prior authorization requests are accurately submitted, tracked, and adjudicated according to Medicare's specific requirements, from initial submission to appeals management.

Frequently asked questions

Does Original Medicare require prior authorization for all Verzenio prescriptions?

No, prior authorization under Original Medicare (Parts A and B) is limited to specific services and programs. If Verzenio is covered under Part B, PA would be routed via the responsible MAC. Medicare Part D plans, however, frequently require PA for specialty drugs like Verzenio.

How do Medicare Administrative Contractors (MACs) impact Verzenio prior authorizations?

MACs are responsible for processing claims and prior authorizations for Original Medicare (Parts A and B) within their specific jurisdictions. They also publish Local Coverage Determinations (LCDs) that define medical necessity criteria. Klivira routes Part B prior authorizations through the appropriate MAC channels.

What role do NCDs and LCDs play in Verzenio prior authorizations under Medicare?

National Coverage Determinations (NCDs) from CMS and Local Coverage Determinations (LCDs) from MACs provide the medical necessity criteria for coverage. Prior authorization requests for Verzenio under Medicare must align with these policies, citing the specific NCD or LCD relevant to the patient's condition and the MAC jurisdiction.

Is CMS-0057-F relevant for Verzenio prior authorizations under Original Medicare?

The CMS-0057-F rule primarily impacts Medicare Advantage, Medicaid managed care, CHIP, and Qualified Health Plans on the Federally Facilitated Marketplace. Its applicability to Traditional Medicare prior authorization programs for drugs like Verzenio is limited, as Original Medicare operates under its own specific program timeframes.

How does Klivira support Verzenio prior authorizations for Medicare patients?

Klivira automates the submission of Verzenio prior authorizations, leveraging MAC-aware routing for Part B submissions and connecting with Part D plan portals. Our platform incorporates NCD/LCD-aware logic to help ensure submissions meet specific Medicare coverage criteria, reducing manual effort and potential delays.

Related coverage

Other verzenio prior authorization by payer

Other verzenio prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo